The Minimal Clinically Important Difference in Vestibular Schwannoma Quality‐of‐Life Assessment
- 2 June 2015
- journal article
- research article
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 153 (2) , 202-208
Abstract
Objective: Several studies have demonstrated small but statistically significant differences in quality‐of‐life (QOL) scores among vestibular schwannoma (VS) treatment modalities. However, does a several‐point difference on a 100‐point scale really matter? The minimal clinically important difference (MCID)—defined as the smallest difference in scores that patients perceive as important and that could lead to a change in management—was developed to answer this important question. While the MCID has been determined for QOL measures used in other diseases, it remains undefined in the VS literature.Study Design: Distribution‐ and anchor‐based techniques were utilized to define the MCID for the Penn Acoustic Neuroma Quality of Life (PANQOL) and 36‐Item Short Form Health Survey (SF‐36).Setting: Two academic referral centers.Patients: Patients with VS (N = 538).Intervention: Cross‐sectional postal survey.Main Outcome Measures: MCID for PANQOL domains and total score and SF‐36 Physical and Mental Health Component Summary scores.Results: The MCID (median, interquartile range) for the PANQOL total score was 11 points (10‐12); the MCIDs for individual domains were as follows: hearing, 6 (5‐8); balance, 16 (14‐19); facial, 10 (no interquartile range); pain, 11 (10‐13); energy, 13 (10‐17); anxiety, 11 (5‐22); and general, 15 (11‐19). The MCID was 7 points (6‐11) for the SF‐36 Mental Health Component Summary score and 8 points (6‐10) for the Physical Health Component Summary score.Conclusions: The MCIDs determined in the current study generally exceed differences reported in previous prospective studies, in which conclusions about QOL benefit (or harm) among VS treatment modalities were based on statistical significance alone. Moving forward, these MCIDs should be considered when interpreting results of VS QOL studies.Keywords
This publication has 31 references indexed in Scilit:
- Systematic review of quality of life in the management of vestibular schwannomaJournal of Clinical Neuroscience, 2011
- Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patientsJournal of Clinical Epidemiology, 2011
- Validation of a disease‐specific quality‐of‐life instrument for acoustic neuromaThe Laryngoscope, 2010
- Quality of Life in Sporadic Vestibular Schwannoma: A ReviewORL, 2010
- Prospective comparison of quality of life before and after observation, radiation, or surgery for vestibular schwannomasJournal of Neurosurgery, 2009
- Surgery for large vestibular schwannomas: how patients and surgeons perceive quality of lifeJournal of Neurosurgery, 2006
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- Measurement of health statusControlled Clinical Trials, 1989
- Measuring change over time: Assessing the usefulness of evaluative instrumentsJournal of Chronic Diseases, 1987
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983